A detailed history of Amalgamated Bank transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 670 shares of BMEA stock, worth $2,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares
670
Previous 670 -0.0%
Holding current value
$2,686
Previous $3,000 133.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$13.92 - $19.5 $29,830 - $41,788
-2,143 Reduced 76.18%
670 $10,000
Q4 2023

Feb 06, 2024

SELL
$8.37 - $19.8 $1,665 - $3,940
-199 Reduced 6.61%
2,813 $41,000
Q2 2023

Aug 11, 2023

BUY
$21.66 - $41.8 $65,239 - $125,901
3,012 New
3,012 $66,000
Q2 2022

Aug 15, 2022

SELL
$3.0 - $12.03 $10,617 - $42,574
-3,539 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$4.39 - $9.03 $15,536 - $31,957
3,539 New
3,539 $16,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $117M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.